Update on Crizotinib from Annual Meeting 2011 (American Society of Clinical Oncology)

videoblog has 63 videos Subscribe Here

Description: The impact of crizotinib, an oral, compound that inhibits the anaplastic lymphoma kinase, or ALK, compared to historical controls, on overall survival in patients with advanced ALK-positive non-small cell lung cancer.
Shared By : videoblog
Posted on : 06/05/11
Added : 7 years ago

More From videoblog

Nothing found.